| Income Statement | 2024-12-31 | |||
|---|---|---|---|---|
| Total revenues | 200,210 | |||
| Total cost of revenues | 57,727 | |||
| Gross profit | 136,737 | |||
| Sales and marketing | 25,029 | |||
| General and administrative | 78,826 | |||
| Technology and development | 26,727 | |||
| Total operating expenses | 130,582 | |||
| Income (loss) from operations | 6,155 | |||
| Other expense, net | -459 | |||
| Interest income, net | 1,693 | |||
| Total non-operating income (expense) | 1,234 | |||
| Income (loss) before income taxes | 7,389 | |||
| Income taxes | 3,474 | |||
| Net income (loss) | 3,915 | |||
| Net income (loss) attributable to non-controlling interests | 1,092 | |||
| Net income (loss) attributable to enfusion, inc | 2,823 | |||
| Basic eps | 0.03 | |||
| Diluted eps | 0.03 | |||
| Basic average shares | 92,045,000 | |||
| Diluted average shares | 129,550,000 | |||
null (ENFN)
null (ENFN)